Research background · Updated November 1, 2026
Livagen Research: Publications, Study Types and Background
Short answer
Livagen. As of November 1, 2026, PubMed indexes 18 records matching Livagen, the earliest from 2001; 1 were published in 2021–2025 and 0 are reviews. ClinicalTrials.gov lists 0 registered studies matching the compound.
- PubMed records
- 18
- Earliest record
- 2001
- Published 2021–2025
- 1
- Reviews
- 0
- Animal-only studies
- 5
- Registered studies
- 0
Publications per year, 2006–2025
3 records in 2016–2025 against 7 in 2006–2015; the busiest year was 2007, with 2.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 0 |
| 2012 | 0 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 0 |
| 2016 | 0 |
| 2017 | 1 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 1 |
| 2021 | 0 |
| 2022 | 0 |
| 2023 | 1 |
| 2024 | 0 |
| 2025 | 0 |
Study types
| All PubMed records | 18 |
|---|---|
| Reviews | 00% |
| Animal studies (no human subjects indexed) | 528% |
| Indexed as clinical trials | 00% |
| Registered on ClinicalTrials.gov | 0 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 2 of the most-cited and most recent Livagen papers report, in their own authors’ terms. Each line links the paper it came from.
Chromosome stability
In lymphocytes from older donors exposed to cobalt chloride, Livagen reduced the number of induced chromosomal changes to 3.4% against 4.2% in controls.
CellsLezhava T 2007Annals of the New York Academy of SciencesPMID 17460203
Chromatin in ageing lymphocytes
In lymphocytes from older individuals, the bioregulator peptides Epitalon, Livagen and Vilon caused activation (deheterochromatinization) of chromatin.
CellsLezhava T 2006Georgian medical newsPMID 16705247
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 18 of the 18 records. They describe what the literature is about, not what Livagen does.
- Aging6 papers
- Chromatin5 papers
- Lymphocytes4 papers
- Oligonucleotides4 papers
- Chromosome Aberrations2 papers
- Cardiomyopathy, Hypertrophic2 papers
- Breast Neoplasms2 papers
- Liver2 papers
Key papers
Earliest indexed record
Khavinson VK (2001). Bulletin of experimental biology and medicine.
PMID 11713572
Citation counts from NIH iCite, among the 18 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 433257-50-2 |
|---|---|
| Molecular formula | C18H31N5O9 |
| Molecular weight | 461.5 g/mol |
| Synonyms | Livagen, orb3212192, SCHEMBL5967826, EX-A16866 |
Identity data from PubChem, retrieved November 1, 2026, on the Livagen page.
How these numbers were counted
- PubMed search, run November 1, 2026:
livagen[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
livagenre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Livagen outside a laboratory.
Wholesale supply
Livagen, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Livagen research questions
How much research has been published on Livagen?
PubMed indexes 18 records matching Livagen (searched November 1, 2026), including 0 reviews and 0 records indexed as clinical trials. 1 were published in the five years 2021–2025.
When was Livagen first described in the literature?
The earliest PubMed record matching Livagen is from 2001 (Khavinson VK, Bulletin of experimental biology and medicine, PMID 11713572).
What topics does the Livagen literature cover?
The subject headings PubMed indexers most often marked as a main topic of Livagen papers are Aging, Chromatin, Lymphocytes, Oligonucleotides. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Livagen sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Livagen wholesale for research?
We source Livagen to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.